Market Overview
The Chemiluminescence Immunoassay (CLIA) Market is entering a period of sustained expansion as healthcare providers, laboratories, and diagnostic companies increasingly prioritize accurate, sensitive, and rapid testing. The market is anticipated to grow from $15.7 billion in 2024 to $30.8 billion by 2034, representing a CAGR of approximately 6.9%. CLIA technology uses...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek